Sign in or create an account to add this stock to your watchlist.
About ERBA Diagnostics (OTCMKTS:ERBA)
ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions
What is ERBA Diagnostics' stock symbol?
ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."
How were ERBA Diagnostics' earnings last quarter?
ERBA Diagnostics (OTCMKTS:ERBA) announced its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.01. The business had revenue of $5.90 million for the quarter, compared to the consensus estimate of $5.16 million. View ERBA Diagnostics' Earnings History.
Who are some of ERBA Diagnostics' key competitors?
Some companies that are related to ERBA Diagnostics include Edge Therapeutics (EDGE), Tonix Pharmaceuticals (TNXP), Vernalis (VNLPY), X T L Biopharmaceuticals (XTLB), Diffusion Pharmaceuticals (DFFN), Egalet (EGLT), Kitov Pharma (KTOV), Eyegate Pharmaceuticals (EYEG), Nuvo Pharmaceuticals (NRIFF), Lipocine (LPCN), Benitec Biopharma (BNTC), Aralez Pharmaceuticals (ARLZ), Citius Pharmaceuticals (CTXR), Jaguar Health (JAGX) and Midatech Pharma (MTP).
Who are ERBA Diagnostics' key executives?
ERBA Diagnostics' management team includes the folowing people:
- Mr. Suresh Vazirani, Exec. Chairman and Managing Director (Age 68)
- Mr. David Barka, Interim Chief Exec. Officer (Age 37)
- Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.
Has ERBA Diagnostics been receiving favorable news coverage?
Media coverage about ERBA stock has trended positive recently, Accern reports. The research group rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. ERBA Diagnostics earned a media sentiment score of 0.42 on Accern's scale. They also assigned news headlines about the company an impact score of 45.30 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of ERBA Diagnostics?
Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ERBA Diagnostics' stock price today?
One share of ERBA stock can currently be purchased for approximately $0.1525.
How big of a company is ERBA Diagnostics?
ERBA Diagnostics has a market capitalization of $7.12 million.
How can I contact ERBA Diagnostics?
ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]
MarketBeat Community Rating for ERBA Diagnostics (ERBA)MarketBeat's community ratings are surveys of what our community members think about ERBA Diagnostics and other stocks. Vote "Outperform" if you believe ERBA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERBA will underperform the S&P 500 over the long term. You may vote once every thirty days.
ERBA Diagnostics (OTCMKTS:ERBA) Analyst Ratings History
(Data available from 5/25/2016 forward)
ERBA Diagnostics (OTCMKTS:ERBA) Earnings History and Estimates Chart
ERBA Diagnostics (OTCMKTS ERBA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/5/2015||Q215||($0.02)||($0.01)||$5.16 million||$5.90 million||View||N/A|
|6/26/2015||Q1 2015||($0.02)||$7.10 million||$4.85 million||View||N/A|
|5/18/2015||Q115||$0.01||($0.01)||$8.10 million||$12.60 million||View||N/A|
|8/12/2014||Q214||$0.01||$6.74 million||$7.54 million||View||N/A|
|4/14/2014||Q4 2013||$0.01||$7.72 million||View||N/A|
|11/14/2012||Q312||($0.01)||$4.06 million||$3.80 million||View||N/A|
ERBA Diagnostics (OTCMKTS:ERBA) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
ERBA Diagnostics (OTCMKTS ERBA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 88.10%
ERBA Diagnostics (OTCMKTS ERBA) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/15/2014||Gopalkrishnan Mohan||CEO||Buy||5,000||$2.89||$14,450.00|| |
ERBA Diagnostics (OTCMKTS ERBA) News Headlines
ERBA Diagnostics (OTCMKTS:ERBA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
ERBA Diagnostics (OTCMKTS ERBA) Stock Chart for Friday, May, 25, 2018